Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.
<h4>Background</h4>Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-gamma1b (rIFN-gammab) may reduce pulmonary inflammation and reduce the period of infectivity by promoting earlier sputum clea...
Saved in:
| Main Authors: | Rod Dawson, Rany Condos, Doris Tse, Maryann L Huie, Stanley Ress, Chi-Hong Tseng, Clint Brauns, Michael Weiden, Yoshihiko Hoshino, Eric Bateman, William N Rom |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2009-09-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0006984&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax.
by: Jeffrey A Gold, et al.
Published: (2007-08-01) -
IMMUNOMODULATING THERAPY BY RECOMBINANT ALPHA-2B INTERFERON AMONG CHILDREN WITH TIMOMEGALIA
by: L.A. Nikulin, et al.
Published: (2007-08-01) -
IMMUNE DISTURBANCES IN PATIENTS WITH EPILEPSY AND OPPORTUNITY OF IMMUNOMODULATION BY RECOMBINANT HUMAN IL-2
by: L. V. Lipatova, et al.
Published: (2016-05-01) -
The Effectiveness of Complex Use of Inosine Pranobex and Recombinant Interferon-
by: E. N. Simovanyan, et al.
Published: (2015-12-01) -
Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis.
by: Anna Nolan, et al.
Published: (2009-08-01)